Edge Health wins PACE health economics work on AMR diagnostics
- Medicines Discovery Catapult
- North West
- Open, 7 bids
- 31 March 2026 to 31 March 2028
Medicines Discovery Catapult (MDC) hired Edge Health Ltd, a small business, for early health economic analysis of AMR diagnostics in the PACE programme. PACE (Pathways to Antimicrobial Clinical Efficacy) is a £30 million effort run jointly by Innovate UK, LifeArc and MDC. The work serves diagnostics developers from PACE's second funding call.
Edge Health maps care pathways for bloodstream, respiratory tract and urinary tract infections and builds a reusable modelling tool with guidance. It then works with each PACE project, feeding in that project's data to produce tailored analyses. Findings are to be made public through open-access tools.
The tender drew seven bids, scored 80% on quality and 20% on price. The firm was awarded the £324,000 contract in February 2026. It runs for two years, with an option of six more months.
Contract ends March 2028
- What
- Health economics and health technology assessment
- Supplier
- Edge Health Ltd
- Value
- £324,000
- How it was bought
- Open
- 7 bids
- Dates and next
- Mar 2026 to Mar 2028
- Option to Feb 2028